COMPOSITION FOR PREVENTING OR TREATING PULMONARY FIBROSIS, COMPRISING TAURODEOXYCHOLIC ACID OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AS ACTIVE INGREDIENT

Abstract

The present invention relates to a composition for preventing or treating pulmonary fibrosis, comprising taurodeoxycholic acid or a pharmaceutically acceptable salt thereof as an active ingredient. More particularly, it was confirmed that pulmonary fibrosis and the expression of pulmonary fibrosis-related factors are reduced in an idiopathic pulmonary fibrosis animal model and a pulmonary fibrosis cell model that are administered with a pharmaceutically acceptable salt of taurodeoxycholic acid, and thus the taurodeoxycholic acid or a pharmaceutically acceptable salt thereof can be used as an active ingredient in the composition for preventing or treating pulmonary fibrosis.

Documents